Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Current medical evidence indicates that ROHHAD is not inherited from parents, but rather occurs as a sporadic, de novo event. While the exact genetic cause of ROHHAD remains unknown despite extensive research, there is no evidence to suggest that it follows a traditional Mendelian inheritance pattern, meaning the risk to siblings or children of an affected individual is considered extremely low. Is ROHHAD considered a hereditary condition? In the field of clinical genetics, we distinguish between a condition being "genetic" and "hereditary." ROHHAD (Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation) is widely believed to be a genetic disorder, but it is not hereditary in the sense that it is passed down through families.
1 people with ROHHAD have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Current medical evidence indicates that ROHHAD is not inherited from parents, but rather occurs as a sporadic, de novo event. While the exact genetic cause of ROHHAD remains unknown despite extensive research, there is no evidence to suggest that it follows a traditional Mendelian inheritance pattern, meaning the risk to siblings or children of an affected individual is considered extremely low.
In the field of clinical genetics, we distinguish between a condition being "genetic" and "hereditary." ROHHAD (Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation) is widely believed to be a genetic disorder, but it is not hereditary in the sense that it is passed down through families. To date, there have been no confirmed cases of ROHHAD occurring in multiple family members. This strongly suggests that ROHHAD arises from a de novo mutation—a spontaneous genetic change that occurs for the first time in the affected individual, rather than being inherited from a parent.
Despite significant advancements in genomic sequencing, the precise genetic driver of ROHHAD has yet to be identified. Researchers have conducted whole-exome and whole-genome sequencing on many patients, yet they have not found a single causative gene. Because the cause remains elusive, we cannot currently provide a specific inheritance pattern such as autosomal dominant or recessive. Some medical researchers hypothesize that ROHHAD may be an autoimmune or paraneoplastic process triggered by a genetic susceptibility, though this remains a subject of ongoing clinical investigation.
For families who have a child with ROHHAD, the lack of a known hereditary pattern is generally reassuring. Because these cases appear to be sporadic, the recurrence risk for future pregnancies is considered to be very low, likely no higher than that of the general population. Genetic counseling is still highly recommended to help families process this information, discuss the latest research, and address any concerns about future pregnancies. Current clinical recommendations include:
Currently, there is no definitive genetic test for ROHHAD. Diagnosis remains a clinical process based on the presence of the hallmark symptoms: rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation. Because there is no biomarker or genetic test, clinicians must rule out other conditions—such as Prader-Willi syndrome or hypothalamic tumors—before confirming a diagnosis of ROHHAD. We encourage families to seek care at specialized academic medical centers that are familiar with the complex, multisystem nature of this rare condition.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any medical diagnosis or treatment.